0001104659-21-089397.txt : 20210706
0001104659-21-089397.hdr.sgml : 20210706
20210706160658
ACCESSION NUMBER: 0001104659-21-089397
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210701
FILED AS OF DATE: 20210706
DATE AS OF CHANGE: 20210706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mendelsohn Alan
CENTRAL INDEX KEY: 0001842511
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37411
FILM NUMBER: 211074124
MAIL ADDRESS:
STREET 1: C/O TIMBER PHARMACEUTICALS, INC.
STREET 2: 50 TICE BLVD., SUITE A26
CITY: WOODCLIFF LAKE
STATE: NJ
ZIP: 07677
FORMER NAME:
FORMER CONFORMED NAME: Mendelsohn Dr. Alan
DATE OF NAME CHANGE: 20210126
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Timber Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001504167
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 593843182
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 110 ALLEN ROAD, SUITE 401
CITY: BASKING RIDGE
STATE: NJ
ZIP: 07920
BUSINESS PHONE: 914-205-3481
MAIL ADDRESS:
STREET 1: 110 ALLEN ROAD, SUITE 401
CITY: BASKING RIDGE
STATE: NJ
ZIP: 07920
FORMER COMPANY:
FORMER CONFORMED NAME: BioPharmX Corp
DATE OF NAME CHANGE: 20140304
FORMER COMPANY:
FORMER CONFORMED NAME: THOMPSON DESIGNS INC
DATE OF NAME CHANGE: 20101022
4
1
tm2121501-3_4.xml
FORM4
X0306
4
2021-07-01
0
0001504167
Timber Pharmaceuticals, Inc.
TMBR
0001842511
Mendelsohn Alan
C/O TIMBER PHARMACEUTICALS, INC
110 ALLEN ROAD, SUITE 401
BASKING RIDGE
NJ
07920
0
1
0
0
Chief Medical Officer
Stock Option (right to buy)
1.18
2021-07-01
4
A
0
347991
0
A
2031-07-01
Common Stock, par value $0.001 per share
347991
347991
D
The option grant was approved by the compensation committee of the board of directors of Timber Pharmaceuticals, Inc. (the "Company") on April 21, 2021, subject to stockholder approval of an amendment to the Company's 2020 Omnibus Equity Incentive Plan (the "Amendment"). The Company's stockholders approved the Amendment on July 1, 2021.
25% of the options vest on July 1, 2022, and the remaining options will vest in 36 equal monthly installments beginning on August 1, 2022 as long as the reporting person remains continuously employed through each vesting date.
/s/ Joseph Lucchese, Power of Attorney
2021-07-06